Skip to main content
Haleon plc (HLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.675
-0.215 (-4.40%)
At close: Dec 5, 2025

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
North America Revenue
3.94B4.04B
Log In
Log In
Log In
Upgrade
EMEA & LatAm Revenue
4.52B4.63B
Log In
Log In
Log In
Upgrade
APAC Revenue
2.56B2.56B
Log In
Log In
Log In
Upgrade

Revenue

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Oral Health Revenue
3.36B3.31B
Log In
Log In
Log In
Upgrade
Vitamins, Minerals and Supplement Revenue
1.67B1.70B
Log In
Log In
Log In
Upgrade
Pain Relief Revenue
2.55B2.56B
Log In
Log In
Log In
Upgrade
Respiratory Health Revenue (Pre-Q2 2025 Reporting)
-1.68B
Log In
Log In
Log In
Upgrade
Digestive Health and Other Revenue (Pre-Q2 2025 Reporting)
-1.98B
Log In
Log In
Log In
Upgrade

Adjusted EBIT by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
North America Adjusted Operating Profit
968.00M1.00B
Log In
Log In
Log In
Upgrade
EMEA & LatAm Adjusted Operating Profit
1.01B1.05B
Log In
Log In
Log In
Upgrade
APAC Adjusted Operating Profit
541.00M539.00M
Log In
Log In
Log In
Upgrade
Corporate Adjusted Operating Profit
-70.00M-93.00M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 2019
Organic Revenue Growth
5.00%
Log In
Log In
Log In
Upgrade
Sales Growth due to Price
3.70%
Log In
Log In
Log In
Upgrade
Sales Growth due to Volume/Mix
1.30%
Log In
Log In
Log In
Upgrade